In the title polymeric compound, [Cu2(HCO2)4(C6H12N4)] n , the Cu(II) atom is five-coordinated in a square-pyramidal geometry that is defined by four O atoms from four formate ligands and one N atom from a hexa-methyl-ene-tetra-mine ligand. The two Cu(II) atoms are separated by 2.6850 (7) Å, and together with the four formate ligands they form a paddle-wheel unit. The hexa-mine ligand uses only...

A mixed culture of an hypermutable hexA Streptococcus pneumoniae mutant strain and its hexA(+) isogenic ancestor was challenged with low cefotaxime concentrations. Despite identical original cefotaxime MICs, the hexA mutant population was significantly selected at very low concentrations, and all of the tested selected variants harbored the Thr550-->Ala mutation in pbp2x. Since cefotaxime selec...

In the title compound, {[Cu2Na2(C10H2O8)1.5(H2O)6]·H2O} n , the Cu(2+) ion is hexa-coordinated by five O atoms from benzene-1,2,4,5-tetra-carboxyl-ate (btec(4-)) ligands and one water mol-ecule. The Na(+) ion is also hexa-coordinated, by four O atoms from btec(4-) ligands and two water mol-ecules. One of the two btec(4-) mol-ecules sits on a crystallographic inversion centre. CuO6 and NaO6 octa...

We have characterized a novel aluminum-based homometallic double complex salt, incorporating discrete octa-coordinated cationic [Al(G3)2](3+) and hexa-coordinated anionic [Al(TfO)4(OH)2](3-) complexes (G3 = triglyme, TfO = trifluoromethanesulfonate). X-ray crystallography, Raman spectra, and DFT calculations demonstrate extraordinary weak Al(3+) coordination in [Al(G3)2](3+).

the microstructure of dual phase steels can be considered as a matrix of ferrite phase reinforced by martensite particles. recent measurements show that the mechanical properties of the ferrite phase are changed with the distance from the martensite grains. in this paper, a new method has been proposed to consider this phenomenon in finite element modeling of dual phase steels microstructure. i...

The severe neurodegenerative disorder, Tays-Sachs disease, is caused by a beta-hexosaminidase alpha-subunit deficiency which prevents the formation of lysosomal heterodimeric alpha-beta enzyme, hexosaminidase A (HexA). No treatment is available for this fatal disease; however, gene therapy could represent a therapeutic approach. We previously have constructed and characterized, in vitro, adenov...